SHANGHAI (Reuters) -China's Innovent Biologics said on Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients with diabetes than injectable semaglutide, the ...

FILE PHOTO: A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey ...

The Healthy China 2030 Plan established a key target of cutting premature deaths from diabetes by 30% by 2030, yet no assessment of diabetes-related premature mortality has been conducted since the ...

SHANGHAI and HONG KONG, March 3, 2026 /PRNewswire/ -- Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator ...

A next-generation triple incretin therapy jointly developed by Novo Nordisk A/S and China’s United Biotechnology outperformed semaglutide in a phase II trial, signaling intensifying competition in the ...

Scientists in China have claimed to have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Type-2 diabetes is prevalent across the world, and in India, and according to ...

SHANGHAI, Dec 8 (Reuters) - Eli Lilly's popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with type 2 diabetes, the National Healthcare ...

- Approval supports a differentiated approach to Type 2 diabetes (T2D) management Global First-in-Class & Local Clinical Data: Establishing a New Model for Restoring Glycemic Homeostasis in Diabetes ...